Amit Chaudhari MD

Neurologist | Neurointensivist | Neurointerventionalist | 🧑‍⚕️👨‍🍼👑

[Amit Chaudhari MD @NeuroIRdoc]

Thrilled to see our new SVIN practice update highlighted on the main stage at #SVIN2025 by @svinsociety President Dr. Thanh Nguyen! 🙌🧠

So grateful to @oozaidat and all my mentors 🙏.. proud to contribute to this important work. 🚀💙

#Stroke #NeuroIntervention @SVINJournal

[Amit Chaudhari MD @NeuroIRdoc]

The population studied (Japan) is so different. 64% of >10mm aneurysms tx with FD, vs only 3% of <10mm. We treat a lot more aneurysms <10mm with FD here.. I wonder if this is more a resource use issue, and if outcomes would be different in U.S. population https://t.co/kcevAZ9eMk

[Amit Chaudhari MD @NeuroIRdoc]

"ultrasound-facilitated, catheter-directed fibrinolysis" for PE.. 🤔 can this be done for #stroke?
https://t.co/Ft5RolLddE

[Amit Chaudhari MD @NeuroIRdoc]

✨ Acute carotid stenting with mechanical thrombectomy is superior with no change in adverse events, prospective ASSIST registry

https://t.co/ytVVttg1JV

[Dhairya A. Lakhani, MD @dhairyalakhani]

GLP-1RA use was associated not only w/ lower intracranial aneurysm rupture risk, but also w/ attenuated rupture severity & less severe outcomes among patients w/ ruptured aneurysms, suggesting potential vascular stabilizing effects.

By @HAlvinChenNeuro

https://t.co/4GLXOqUk0b

[Amit Chaudhari MD @NeuroIRdoc]

"CREST-2 reminds us that the goal is not simply to perform procedures—it is to ensure that the right patients receive the right treatment at the right time." 💛

@CaitlinWHicks
@NN_publishing

https://t.co/3h5cDRyQZC.

[Amit Chaudhari MD @NeuroIRdoc]

LVOne assay for GFAP

✨ 92% specificity
✨ 97% negative predictive value

Nice work 💪 👏

https://t.co/6YlbX29RLp

[Ashkan Shoamanesh @Ash_Shoamanesh]

Many thanks to @CTVNews for covering our efforts in the INTERCEPT trial testing a novel carotid filter system designed improve secondary #stroke prevention in patients with atrial fibrillation (#AF).
https://t.co/q6RNl6121b

@HamHealthSci @MacDeptMed @McmasterStroke @CTVToronto

[Amit Chaudhari MD @NeuroIRdoc]

Congrats @DrAltschul 👏

[Dorothea Altschul MD FAHA FSVIN @DrAltschul]

Honored to be named Physician of the Year by the American Heart Association. Proud to serve this community for 16 years. ❤️🧠 @AHANewJersey

[Amit Chaudhari MD @NeuroIRdoc]

Oriental MeVO

✨ "Some patients with stroke due to MeVO — specifically those with a younger age, higher stroke severity, and early presentation who are not treated with thrombolysis — will be most likely to benefit from endovascular thrombectomy."
https://t.co/y9fPCtBJZx.

[Amit Chaudhari MD @NeuroIRdoc]

Milli-spinner by Renee Zhao and @JeremyHeitMDPHD .. maybe the future of #thrombectomy

[Amit Chaudhari MD @NeuroIRdoc]

Crazy exciting talk about #innovation in NeuroIR by @_AdnanSiddiqui

[Amit Chaudhari MD @NeuroIRdoc]

ACTISAVE trial negative for adding platelt inhibitor to thrombolysis. But I wonder if pt selection was just too broad.. 🤔

Not all strokes are same

Glenzocimab, a platelet glycoprotein VI antagonist, inhibits platelet activation and aggregation

https://t.co/X1Zpr2J5M4

[SVIN @svinsociety]

#ResearchTuesday Does single-plane angiography compromise #thrombectomy outcomes for LVO #stroke?

Propensity-matched analysis (100 pts, 3 centers): single-plane vs biplane showed no significant differences in reperfusion (90% vs 94%), 90d good outcome (61% vs 43%), or complications. Single-plane systems are a viable, cost-effective option for expanding thrombectomy access to proximal anterior circulation LVOs in resource-limited settings where <3% of global demand is met. Gautam et al., Stroke Vasc Interv Neurol. 2026

https://t.co/TqoS3u2GCF

@SVINJournal @rgrandhi
#Stroke #Thrombectomy #GlobalHealth #NeuroIR #SkimWithSVIN

[JAMA Neurology @JAMANeuro]

📊 JAMA Research Summary: In acute #ischemicstroke without large or medium vessel occlusion, adjunctive #tirofiban after poor tenecteplase response increased excellent 90-day outcomes without excess bleeding or mortality.

#ESOC2026 @ESOstroke

https://t.co/z1eNgQG4EO

[NeuroNews @NN_publishing]

Bruce Campbell presents new EXTEND-IA data indicating that, while recombinant human DNAse 1 adjunctive to IVT in LVO stroke didn't meet its primary efficacy endpoint, an "excellent" safety profile was achieved alongside dose-dependent increases in reperfusion
#ESOC2026 @ESOstroke

[NeuroNews @NN_publishing]

New findings from the @TECNO_Trial reveal that giving TNK in patients with incomplete reperfusion after thrombectomy is safe but ultimately does not lead to improved early (25 min) nor late (24hr) reperfusion
#ESOC2026 @ESOstroke @CheesemakerMD @FishingNeurons

[Seemant Chaturvedi @ChaturvediNeuro]

In OCEANIC STROKE, pts with stroke during the trial had lower likelihood of having NIHSS of 8 or higher with asundexian treatment #ESOC2026 ⁦@AANmember⁩

[Seemant Chaturvedi @ChaturvediNeuro]

CHILL ART study reports improved outcome with EVT plus hypothermia vs EVT alone. Only 0.4 degree difference in treatment groups. Replication in other populations needed #ESOC2026 ⁦@svinsociety⁩

[IL @italolinfante]

Prolong’s investigational therapy for acute ischaemic stroke receives US FDA breakthrough therapy designation https://t.co/d9nvIkCI1U #stroke